CHHHF:OTC-CareRx Corporation (USD)

COMMON STOCK | Medical Care Facilities | OTC

Last Closing Price

USD 4.28

Change

0.00 (0.00)%

Market Cap

USD 0.13B

Average Target Price

USD 7.00 (+63.55%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-09 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
FSNUF Fresenius SE & Co. KGaA

+2.71 (+6.25%)

USD25.14B 12.04 7.33
FSNUY Fresenius SE & Co. KGaA

+0.18 (+1.54%)

USD24.92B 12.65 7.33
FMCQF Fresenius Medical Care AG & Co..

+1.30 (+1.75%)

USD21.76B 15.94 8.47
SKHCF Sonic Healthcare Limited

-0.41 (-1.48%)

USD13.07B 18.25 7.44
SKHHY Sonic Healthcare Limited

-0.22 (-0.79%)

USD13.07B 18.02 7.44
RMYHY Ramsay Health Care Limited

+0.02 (+0.15%)

USD11.82B 62.13 11.30
RMSYF Ramsay Health Care Limited

N/A

USD11.73B 59.13 11.30
IHHHF IHH Healthcare Berhad

N/A

USD11.44B 244.00 6.51
BDUUF Bangkok Dusit Medical Services..

N/A

USD10.90B 50.00 0.62
BDUUY Bangkok Dusit Medical Services..

N/A

USD10.90B 38.97 0.62

ETFs Containing CHHHF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.70% 61% D- 62% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.70% 63% D 62% D-
Trailing 12 Months  
Capital Gain 64.62% 58% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.62% 58% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -11.41% 21% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.41% 20% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 43.30% 56% F 49% F
Risk Adjusted Return -26.35% 25% F 20% F
Market Capitalization 0.13B 60% D- 54% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.40 73% C 63% D
Price/Book Ratio 14.32 12% F 12% F
Price / Cash Flow Ratio 581.68 3% F 1% F
EV/EBITDA 14.69 25% F 26% F
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital -1.74% 21% F 39% F
Return on Assets -0.48% 33% F 50% F
Debt to Equity Ratio 636.54% 2% F 2% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.68 50% F 59% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector